Metabolic myopathies

Seminars in Pediatric Neurology

Volumn 3, Issue 2, 1996, Pages 59-98

  Tein, I ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

6 PHOSPHOFRUCTOKINASE; ACYL COENZYME A DEHYDROGENASE; ADENOSINE MONOPHOSPHATE DEAMINASE; CARNITINE PALMITOYLTRANSFERASE; ENOYL COENZYME A HYDRATASE; GLYCOGEN PHOSPHORYLASE B; LACTATE DEHYDROGENASE; MITOCHONDRIAL DNA; PHOSPHOGLYCERATE KINASE; PHOSPHOGLYCERATE MUTASE; PHOSPHORYLASE;

CLINICAL FEATURE; ENZYME DEFICIENCY; FATTY ACID OXIDATION; GENE DELETION; GENETIC LINKAGE; GLYCOGEN STORAGE DISEASE TYPE 5; HUMAN; MITOCHONDRIAL RESPIRATION; MUSCLE CRAMP; MUSCLE WEAKNESS; MYALGIA; MYOGLOBINURIA; PATHOGENESIS; REVIEW;

EID: 0029948860     PISSN: 10719091     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1071-9091(96)80038-6     Document Type: Article

References (357)

1. Felig P Wahren J Fuel homeostasis in exercise N Engl J Med 293 1975 1078 1084
2. Wahren J Glucose turnover during exercise in man Ann N Y Acad Sci 301 1977 45 55
3. Essen B Intramuscular substrate utilization during prolonged exercise Ann N Y Acad Sci 301 1977 30 44
4. Gollnick PD Piehl K Saltin B Selective glycogen depletion pattern in human muscle fibres after exercise of varying intensity and at varying pedalling rates J Physiol 241 1974 45 57
5. Essen B Glycogen depletion of different types in human skeletal muscle during intermittent and continuous exercise Acta Physiol Scand 103 1978 446 455
6. Lithell H Orlander J Schele R Changes in lipoprotein-lipase activity and lipid stores in human skeletal muscle with prolonged heavy exercise Acta Physiol Scand 107 1979 257 261
7. McArdle B Myopathy due to a defect in muscle glycogen breakdown Clin Sci 10 1951 13 35
8. Tarui S Okuno G Ikura Y Phosphofructokinase deficiency in skeletal muscle: a new type of glycogenosis Biochem Biophys Res Commun 19 1965 517 523
9. Layzer RB Rowland LP Ranney HM Muscle phosphofructokinase deficiency Arch Neurol 17 1967 512 523
10. (abstr) DiMauro S Dalakas M Miranda AF Phosphoglycerate kinase (PGK) deficiency: A new cause of recurrent myoglobinuria Ann Neurol 10 1981 90
11. DiMauro S Miranda AF Khan S Human muscle phosphoglycerate mutase deficiency: A newly discovered metabolic myopathy Science 212 1981 1277 1279
12. Kanno T Sudo K Takeuchi I Hereditary deficiency of lactate dehydrogenase M-subunit Clin Chim Acta 108 1980 267 276
13. Abarbanel JM Bashan N Potashnik R Adult muscle phosphorylase ‘b’ kinase deficiency Neurology 36 1986 560 562
14. Brown BI Debranching and branching enzyme deficiencies Engel AG Banker B Myology 1986 McGraw-Hill New York, NY 1653 1661
15. DiMauro S DiMauro PMM Muscle carnitine palmitoyltransferase deficiency and myoglobinuria Science 182 1973 929 931
16. Roe CR Stanley CA New genetic defects in mitochondrial fatty acid oxidation and carnitine deficiency Adv Pediatr 34 1987 59 88
17. Tein I De Vivo DC Hale DE Short-chain L-3-hydroxyacyl-CoA dehydrogenase deficiency in muscle: A new cause for recurrent myoglobinuria and encephalopathy Ann Neurol 30 1991 415 419
18. Dionisi-Vici C Burlina AB Bertini E Progressive neuropathy and recurrent myoglobinuria in a child with long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency J Pediatr 118 1991 744 746
19. Bresolin N Bet L Moggio M Muscle glucose-6-phosphate dehydrogenase deficiency J Neurol 236 1989 193 198
20. (abstr) Hyser CL Clarke PRH DiMauro S Myoadenylate deaminase deficiency and exertional myoglobinuria Neurology 39 1989 335
21. Haller RG Henriksson KG Jorfeldt L Deficiency of skeletal muscle succinate dehydrogenase and aconitase. Pathophysiology of exercise in a novel human muscle oxidative defect J Clin Invest 88 1991 1197 1206
22. Ogasahara S Engel AG Frens D Muscle coenzyme Q deficiency in familial mitochondrial encephalomyopathy Proc Natl Acad Sci U S A 86 1989 2379 2382
23. Ohno KM Tanaka K Sahashi T Mitochondrial DNA deletions in inherited recurrent myoglobinuria Ann Neurol 29 1991 364 369
24. Engel WK Vick NA Glueck CJ A skeletal-muscle disorder associated with intermittent symptoms and a possible defect of lipid metabolism N Engl J Med 282 1970 697 704
25. Bonilla E Chang HW Miranda AF Duchenne muscular dystrophy: The disease, the protein Benzi G Advances in Myochemistry II 1989 John Libbey Eurotext Toronto-Paris 173 184
26. Hoffman EP Kunkel LM Angelini C Improved diagnosis of Becker muscular dystrophy by dystrophin testing Neurology 39 1989 1011 1017
27. Medori R Brooke MH Waterston R Two dissimilar brothers with Becker's dystrophy have an identical genetic defect Neurology 39 1989 1493 1496
28. (62) Tein I DiMauro S Rowland LP Myoglobinuria Rowland LP DiMauro S Handbook of Clinical Neurology vol. 18 1992 Myopathies. Elsevier Amsterdam, The Netherlands 553 593
29. Rowland LP Myoglobinuria Can J Neurol Sci 11 1984 1 13
30. Tonin P Lewis P Servidei S Metabolic causes of myoglobinuria Ann Neurol 27 1990 181 185
31. Tein I DiMauro S De Vivo DC Recurrent childhood myoglobinuria Adv Pediatr 37 1990 77 117
32. DiMauro S Miranda AF Sakoda S Metabolic myopathies Am J Med Genet 25 1986 635 651
33. Engel AG Hirschhorn R Acid maltase deficiency Engel AG Banker BQ Myology vol 2 1994 McGraw-Hill New York, NY 1533 1553
34. Francke U Darras BT Zander NF Assignment of human genes for phosphorylase kinase subunits alpha (PHKA) to Xq12–q13 and beta (PHKB) to 16q12–q13 Am J Hum Genet 45 1989 276 282
35. Davidson JJ Özçelik T Hamacher C cDNA cloning of a liver isoform of the phosphorylase kinase α subunit and mapping of the gene to Xp22.2–p22.1, the region of human X-linked liver glycogenosis Proc Natl Acad Sci U S A 89 1992 2096 2100
36. Jones TA da Cruz e Silva EF Spurr NK Localization of the gene encoding the catalytic gamma subunit of phosphorylase kinase to human chromosome bands 7p12–q21 Biochim Biophys Acta 1048 1990 24 29
37. Lebo RV Gorin F Fletterick RJ High-resolution chromosome sorting and DNA spot-blot analysis assign McArdle's syndrome in chromosome 11 Science 225 1984 57 59
38. Newgard CB Nakano K Hwang PK Sequence analysis of the cDNA encoding human liver glycogen phosphorylase reveals tissue-specific codon usage Proc Natl Acad Sci U S A 83 1986 8132 8136
39. Newgard CB Littman DR van Genderen C Human brain glycogen phosphorylase; Cloning, sequence analysis, chromosomal mapping, tissue expression and comparison with the human liver and muscle isozymes J Biol Chem 263 1988 3850 3857
40. Yang-Feng TL Zheng K Yu J Assignment of the human glycogen debrancher gene to chromosome 1p21 Genomics 13 1992 931 934
41. Vora S Durham S deMartinville B Assignment of the human gene for muscle-type phosphofructokinase (PFKM) to chromosome 1 (region cen-q32) using somatic cell hybrids and monoclonal anti-M antibody Som Cell Genet 8 1982 95 104
42. Vora S Miranda AF Hernandez E Regional assignment of the human gene for platelet-type phosphofructokinase (PFKP) to chromosome 10p: Novel use of polyspecific rodent antisera to localize human enzyme genes Hum Genet 63 1983 374 379
43. Van Keuren M Drabkin H Hart I Regional assignment of human liver-type 6-phosphofructokinase to chromosome 21q22.3 by using somatic cell hybrids and a monoclonal anti-L antibody Hum Genet 74 1986 34 40
44. Meera Khan P Westerveld A Grzeschik KH X-linkage of human phosphoglycerate kinase confirmed in man-mouse and man-Chinese hamster somatic cell hybrids Am J Hum Genet 23 1971 614 623
45. Edwards YH Sakoda S Schon EA The gene for human muscle-specific phosphoglycerate mutase, PGAMM, mapped to chromosome 7 by polymerase chain reaction Genomics 5 1989 948 951
46. Junien C Despoisse S Turleau C Assignment of phosphoglycerate mutase (PGAMA) to human chromosome 10: Regional mapping of GOT1 and PGAMA subbands 10q26.1 (or q25.3) Ann Genet 25 1982 25 27
47. Boone CM Chen TR Ruddle FH Assignment of three human genes to chromosomes (LDH-A to 11, TK to 17, and IDH to 20) and evidence for translocation between human and mouse chromosomes in somatic cell hybrids Proc Natl Acad Sci U S A 69 1972 510 514
48. Chen TR McMorris FA Creagan R Assignment of the genes for malate oxidoreductase to chromosome 6 and peptidase B and lactate dehydrogenase B to chromosome 12 in man Am J Hum Genet 25 1973 200 207
49. DiMauro S Tsujino S Nonlysosomal glycogenoses Engel AG Banker BQ Myology vol 2 1994 McGraw Hill New York, NY 1554 1576
50. Lewis SF Haller RG The pathophysiology of Mc-Ardle's disease: Clues to regulation in exercise and fatigue J Appl Physiol 61 1986 391 401
51. 2 transport in muscle phosphofructokinase deficiency J Appl Physiol 70 1991 391 398
52. Haller RG Lewis SF Cook JD Myophosphorylase deficiency impairs muscle oxidative metabolism Ann Neurol 17 1985 196 199
53. (62) DiMauro S Tonin P Servidei S Metabolic myopathies Rowland LP DiMauro S Handbook of Clinical Neurology vol 18 1992 Elsevier Myopathies, Amsterdam, The Netherlands 479 526
54. Pompe JC Over idiopatische hypertrophie van het hart Ned Tijdschr Geneeskd 76 1932 304 311
55. Mehler M DiMauro S Residual acid maltase activity in late-onset acid maltase deficiency Neurology 27 1977 178 184
56. Reuser AJJ Kroos M Willemsen R Clinical diversity in glycogenosis type II J Clin Invest 79 1987 1689 1699
57. Van Der Ploeg AT Bolhuis PA Wolterman RA Prospect for enzyme therapy in glycogenosis type II variants: a study on cultured muscle cells J Neurol 235 1988 392 396
58. Martiniuk F Mehler M Tzall S Sequence of the cDNA and 5′-flanking region for human acid alpha-glucosidase, detection of an intron in the 5′ untranslated leader sequence, definition of 18-bp polymorphisms, and differences with previous cDNA and amino acid sequence DNA Cell Biol 9 1990 85 94
59. Martiniuk F Mehler M Tzall S Extensive genetic heterogeneity in patients with alpha glucosidase deficiency as detected by abnormalities of DNA and mRNA Am J Hum Genet 47 1990 73 78
60. Slonim AE Coleman RA McElligot MA Improvement of muscle function in acid maltase deficiency by high-protein therapy Neurology 33 1983 34 38
61. Van der Berg IET Berger R Phosphorylase b Kinase Deficiency in Man: a Review J Inherited Metab Dis 13 1990 442 451
62. Carrier H Maire I Vial C Myopathic evolution of an exertional muscle pain syndrome with phosphorylase b kinase deficiency Acta Neuropathol 81 1990 84 88
63. Mizuta K Hashimoto E Tsutou A A new type of glycogen storage disease caused by deficiency of cardiac phosphorylase kinase Biochem Biophys Res Commun 119 1984 582 587
64. Servidei S Metlay LA Chodosh J Fatal infantile cardiopathy cause by phosphorylase b kinase deficiency J Pediatr 113 1988 82 85
65. Heilmeyer LMG Molecular basis of signal integration in phosphorylase kinase Biochim Biophys Acta 1094 1991 167 174
66. Willems PJ Hendrickx J Van der Auwera BJ Mapping of the gene for X-linked liver glycogenosis due to phosphorylase kinase deficiency to human chromosome region Xp22 Genomics 9 1991 565 569
67. Harmann B Zander NF Kilimann MW Isoform diversity of phosphorylase kinase α and β subunits generated by alternative RNA splicing J Biol Chem 266 1991 15631 15637
68. DiMauro S Bresolin N Phosphorylase deficiency Engel AG Banker BQ Myology 1986 McGraw-Hill New York, NY 1585 1601
69. Pourmand R Sanders DB Corwin HM Late-onset McArdle's disease with unusual electromyographic findings Arch Neurol 40 1983 374 377
70. DiMauro S Hartlage PL Fatal infantile form of muscle phosphorylase deficiency Neurology 28 1978 1124 1129
71. Milstein JM Herron TM Haas JE Fatal infantile muscle phosphorylase deficiency J Child Neurol 4 1989 186 188
72. 31P MRS) in neuromuscular disorders Ann Neurol 30 1991 90 97
73. 31P nuclear magnetic resonance N Engl J Med 304 1981 1338 1342
74. Schimrigk K Mertens HG Ricker K McArdle-Syndrom (Myopathie bei fehlender Muskelphosphorylase) Klin Wochenschr 45 1967 1 17
75. Chui LA Munsat TL Dominant inheritance of McArdle syndrome Arch Neurol 33 1976 636 641
76. Schmidt B Servidei S Gabbai AA McArdle's disease in two generations: Autosomal recessive transmission with manifesting heteroxygote Neurology 37 1987 1558 1561
77. Papadimitriou A Manta P Divari R Two clinical expressions in the same pedigree J Neurol 237 1990 267 270
78. Tsujino S Shanske S DiMauro S Molecular genetic heterogeneity of myophosphorylase deficiency (McArdle's disease) N Engl J Med 329 1993 241 245
79. Takeuchi T Kuriaki H Histochemical detection of phosphorylase in animal tissues J Histochem Cytochem 3 1955 153 160
80. Sato K Imai F Hatayama I Characterization of glycogen phosphorylase isoenzymes present in cultured skeletal muscle from patients with McArdle's disease Biochem Biophys Res Commun 78 1977 663 668
81. DiMauro S Arnold S Miranda AF The mystery of reappearing phosphorylase activity in muscle culture. A fetal isoenzyme Ann Neurol 3 1978 60 66
82. Servidei S Shanske S Zeviani M McArdle disease. Biochemical and molecular genetic studies Ann Neurol 24 1988 774 781
83. McConchie SM Coakley J Edwards RHT Motecular heterogeneity in McArdle's disease Biochim Biophys Acta 1096 1991 26 32
84. Bresolin N Miranda AF Jacobsen MP Phosphorylase isoenzymes of human brain Neurochem Pathol 1 1983 171 178
85. Franec Lewis SF Haller RG Fatigue in skeletal muscle disorders Atlan G Belivau L Bouissou P Muscle fatigue: Biochemical and physiological aspects 1991 Masson Paris 119 134
86. Wabren J Felig P Havel RJ Amino acid metabolism in McArdle's syndrome N Engl J Med 288 1973 774 777
87. Slonim AE Goans PJ Myopathy in McArdle's syndrome. Improvement with a high protein diet N Engl J Med 312 1985 355 359
88. Smit GPA Fernandes J Leonard JV The long-term outcome of patients with glycogen storage diseases J Inherit Metab Dis 13 1990 411 418
89. Fellows IW Lowe JS Ogilvie AL Type III glycogenosis presenting as liver disease in adults with atypical histological features J Clin Pathol 36 1983 431 434
90. Ozand P Tokatli M Amiri S Biochemical investigation of an unusual case of glycogenosis J Pediatr 71 1967 225 232
91. Murase T Ikeda H Muro T Myopathy associated with type III glycogenosis J Neurol Sci 20 1973 287 295
92. Badurska G Fidzianska A Kwiatkowska Z Muscular glycogenosis type III in a 15-year-old boy Neuropathol Pol 8 1970 265 270
93. Slonim AE Weisberg C Benke P Reversal of debrancher deficiency myopathy by the use of high-protein nutrition Ann Neurol 11 1982 420 422
94. Moses SW Gadoth N Bashan N Neuromuscular involvement in glycogen storage disease type III Acta Paediatr Scand 75 1986 289 296
95. Moses SW Wanderman KL Myroz A Cardiac involvement in glycogen storage disease type III Eur J Pediatr 148 1989 764 766
96. Miller CG Alleyne GA Brooks SEH Gross cardiac involvement in glycogen storage disease type III Br Heart J 34 1972 862 864
97. Brunberg JA McCormick WF Schochet SS Type III glycogenosis: An adult with diffuse weakness and muscle wasting Arch Neurol 25 1971 171 178
98. Yang BZ, Ding JH, Brown BI et al.: Definitive prenatal diagnosis for type III glycogen storage disease Am J Hum Genet 47: 735–739
99. Sancho S Navarro C Fernández J Skin biopsy findings in glycogenosis III: Clinical, biochemical, and electrophysiological correlations Ann Neurol 27 1990 480 486
100. Miranda AF DiMauro S Antler A Glycogen debrancher deficiency in reproduced in muscle culture Ann Neurol 9 1981 283 288
101. Olson LJ Reeder GS Edwards WD Cardiac involvement in glycogen storage disease III: Morphologic and biochemical characterization with endomyocardial biopsy Am J Cardiol 53 1984 980 981
102. Powell HC Haas R Hall CL Peripheral nerve in type III glycogenosis: Selective involvement of unmyelinated fiber Schwann cells Muscle Nerve 8 1985 667 671
103. Ugawa Y Inoue K Takemura T Accumulation of glycogen in sural nerve axons in adult-onset type III glycogenosis Ann Neurol 19 1986 294 297
104. (abstr) Hug G Schubert WK Glycogenosis associated with degenerative disease of the brain: Biochemical and electron microscopic findings Clin Res 14 1966 441
105. Bates EJ Heaton GM Taylor C Debranching enzyme from rabbit skeletal muscle: Evidence for the location of two active centers on a single polypeptide chain FEBS Lett 58 1975 181 185
106. Chen YT He JK Ding JH Glycogen debranching enzyme: Purification, antibody characterization, and immunoblot analysis of type III glycogen storage disease Am J Hum Genet 41 1987 1002 1015
107. Ding JH DeBarsy TH Brown BI Immunoblot analysis of glycogen debranching enzyme in different subtypes of glycogen storage disease type III J Pediatr 116 1990 95 100
108. Yang BZ Ding JH Enghild JJ Molecular cloning and nucleotide sequence of cDNA encoding human muscle glycogen debranching enzyme J Biol Chem 267 1992 9294 9299
109. Fernandes J The glycogen storage diseases Fernandes J Saudubray JM Tada K Inborn Metabolic Diseases 1990 Springer-Verlag Berlin, Germany 69 88
110. Rowland LP DiMauro S Layzer RB Phosphofruc tokinase deficiency Engel AG Banker BQ Myology 1986 McGraw-Hill New York, NY 1603 1617
111. Amit R Bashan N Abarbanel JM Fatal familial infantile glycogen storage disease: Multisystem phosphofructokinase deficiency Muscle Nerve 15 1992 455 458
112. Kahn A Etiemble J Meienhofer MC Erythrocyte phosphofructokinase deficiency associated with an unstable variant of muscle phosphofructokinase Clin Chim Acta 61 1975 415 419
113. Etiemble J Kahn APB Hereditary hemolytic anemia with erythrocyte phosphofructokinase deficiency Hum Genet 31 1976 83 91
114. Bonilla E Schotland DL Histochemical diagnosis of muscle phosphofructokinase deficiency Arch Neurol 22 1970 8 12
115. Hays AP Hallett M Delfs J Muscle phosphofructokinase deficiency: Abnormal polysaccharide in a case of late-onset myopathy Neurology 31 1981 1077 1096
116. Vora S Isozymes of human phosphofructokinase: Biochemical and genetic aspects Isozymes 11 1983 3 23
117. Vora S Davidson M Seaman C Heterogeneity of the molecular lesions in inherited phosphofructokinase deficiency J Clin Invest 72 1983 1995 2006
118. Haller RG Lewis SF Glucose-induced exertional fatigue in muscle phosphofructokinase deficiency N Engl J Med 324 1991 364 369
119. Mineo I Kono N Hara N Myogenic hyperuricemia. A common pathophysiologic feature of glycogenosis types III, V, and VII N Engl J Med 317 1987 75 80
120. Nakajima H Noguchi T Yamasaki T Cloning of human muscle phosphofructokinase cDNA FEBS Lett 223 1987 113 116
121. Nakajima H Kono N Yamasaki T Tissue specificity in expression and alternative RNA splicing of human phosphofructokinase-M and L-genes Biochem Biophys Res Commun 173 1990 1317 1321
122. Valentine WM Hsieh H Paglia DE Hereditary hemolytic anemia associated with phosphoglycerate kinase deficiency in erythrocytes and leukocytes N Engl J Med 280 1960 528 534
123. Boivin P Hakim J Manderau J Deficit en 3-phosphoglycerate kinase erythrocytaire et leucocytaire Nouv Rev Fr Hematol 14 1974 495 508
124. Rosa R George C Fardeau M A new case of phosphoglycerate kinase deficiency: PGK Creteil associated with rhabdomyolysis and lacking hemolytic anemia Blood 60 1982 84 91
125. DiMauro S Dalakas M Miranda AF Phosphoglycerate kinase deficiency: Another cause of recurrent myoglobinuria Ann Neurol 13 1983 11 19
126. Tonin P Shanske S Miranda AF Phosphoglycerate kinase deficiency: biochemical and molecular genetic studies in a new myopathic variant (PGK Alberta) Neurology 43 1993 387 391
127. Huang I-Y Rubinfien E Yoshida A Complete aminoacid sequence of human phosphoglycerate kinase: Isolation and aminoacid sequence of tryptic peptides J Biol Chem 255 1980 6408 6411
128. Huang I-Y Welch CD Yoshida A Complete amino-acid sequence of human phosphoglycerate kinase: Cyanogen bromide peptides and complete amino acid sequence J Biol Chem 255 1980 6412 6420
129. Sugie H Sugie Y Nishida M Recurrent myoglobinuria in a child with mental retardation: Phosphoglycerate kinase deficiency J Child Neurol 4 1989 95 99
130. Michelson AM Markham AF Orkin SH Isolation and DNA sequence of a full-length cDNA clone for human X chromosome encoded phosphoglycerate kinase Proc Natl Acad Sci USA 80 1983 472 476
131. DiMauro S Miranda AF Khan S Human muscle phosphoglycerate mutase deficiency: A newly discovered metabolic myopathy Science 212 1981 1277 1279
132. DiMauro S Miranda AF Olarte M Muscle phosphoglycerate mutase deficiency Neurology 32 1982 584 591
133. Omenn GS Cheung CY Phosphoglycerate mutase isozyme marker for tissue differentiation in man Am J Hum Genet 26 1974 393 399
134. Omenn GS Hermodson MA Human phosphoglycerate mutase: Isozyme marker for muscle differentiation and neoplasia Markert CM Isozymes: III. Developmental Biology 1975 Academic Press New York, NY 1005 1018
135. Servidei S DiMauro S Disorders of glycogen metabolism of muscle Neurol Clin 7 1989 159 178
136. Kissel JT Beam W Bresolin N Physiologic assessment of phosphoglycerate mutase deficiency: Incremental exercise tests Neurology 35 1985 828 833
137. Argov Z Bank WJ Boden B Phosphorus magnetic resonance spectroscopy of partially blocked muscle glycolysis Arch Neurol 44 1987 614 617
138. Shanske S Sakoda S Hermodson MA Isolation of a cDNA encoding the muscle-specific subunit of human phosphoglycerate mutase J Biol Chem 262 1987 14612 14617
139. Tsujino S Sakoda S Mizuno R Structure of the gene encoding the muscle-specific subunit of human phosphoglycerate mutase J Biol Chem 264 1989 15334 15337
140. Tsujino S Shanske S Sakoda S The molecular genetic basis of muscle phosphoglycerate mutase (PGAM) deficiency Am J Hum Genet 52 1993 472 477
141. Sakoda S Shanske S DiMauro S Isolation of a cDNA encoding the B isozyme of human phosphoglycerate mutase (PGAM) and characterization of the PGAM gene family J Biol Chem 263 1988 16899 16905
142. (abstr) Bryan W Lewis SF Bertocci L Muscle lactate dehydrogenase deficiency: A disorder of anaerobic glycogenolysis associated with exertional myoglobinuria Neurology 40 1990 203
143. Maekawa M Kanda S Sudo K Estimation of the gene frequency of lactate dehydrogenase subunit deficiencies Am J Hum Genet 36 1984 1204 1214
144. Fernandes J Huijing F Branching enzyme-deficiency glycogenosis: Studies in therapy Arch Dis Child 43 1968 347 352
145. Zellweger H Mueller S Ionasescu V Glycogenosis: IV. A new cause of infantile hypotonia J Pediatr 80 1972 842 844
146. Servidei S Riepe RE Langston C Severe J Pediatr 111 1987 51 56
147. Farrans VJ Hibbs RG Walsh JJ Cardiomyopathy, cirrhosis of the liver and deposits of a fibrillar polysaccharide Am J Cardiol 17 1966 457 469
148. Lossos A Barash V Soffer D Hereditary branching enzyme dysfunction in adult polyglucosan body disease: A possible metabolic cause in two patients Ann Neurol 30 1991 655 662
149. Bruno C Servidei S Shanske S Glycogen branching enzyme deficiency in adult polyglucosan body disease Ann Neurol 33 1993 88 93
150. Cafferty MS Lovelace RE Hays AP Polyglucosan body disease Muscle Nerve 14 1991 102 107
151. Brown BI Brown DH Branching enzyme activity of cultured amniocytes and chorionic villi: Prenatal testing for type IV glycogen storage disease Am J Hum Genet 44 1989 378 381
152. Selby R Starzl TE Yunis E Liver transplantation for type IV glycogen storage disease N Engl J Med 324 1991 39 42
153. Sokal EM Van Hoof F Alberti D Progressive cardiac failure following orthotopic liver transplantation for type IV glycogenosis Eur J Pediatr 151 1992 200 203
154. Stanley CA Hale DE Coates PM Medium-chain acyl-CoA dehydrogenase deficiency in children with non-ketotic hypoglycemia and low carnitine levels Pediatr Res 17 1983 877 884
155. Hale DE Batshaw ML Coates PM Long-chain acyl coenzyme A dehydrogenase deficiency: An inherited cause of nonketotic hypoglycemia Pediatr Res 19 1985 666 671
156. Duran M Hofkamp M Rhead WJ Sudden child death and ‘healthy’ affected family members with medium-chain acyl-coenzyme A dehydrogenase deficiency Pediatrics 78 1986 1052 1057
157. Howat AJ Bennett MJ Variend S Defects of metabolism of fatty acids in the sudden infant death syndrome Br Med J 290 1985 1771 1773
158. Amendt BA Greene C Sweetman L Short-chain acyl-coenzyme A dehydrogenase deficiency. Clinical and biochemical studies in two patients J Clin Invest 79 1987 1303 1309
159. Taubman B Hale DE Kelley RI Familial Reye-like syndrome: A presentation of medium-chain acyl-coenzyme A dehydrogenase deficiency Pediatrics 79 1987 382 385
160. Gibson EM Breuer J Nyhan WL 3-Hydroxy-3-methylglutaryl-coenzyme A lyase deficiency: review of 18 reported patients Eur J Pediatr 148 1988 180 186
161. Demaugre F Bonnefont J-P Mitchell G Hepatic and muscular presentations of carnitine palmitoyl-transferase deficiency: Two distinct entities Pediatr Res 24 1988 308 311
162. Frerman FE Goodman SI Glutaric aciduria type II and defects of the mitochondrial respiratory chain Scriver CR Beaudet AL Sly WS The Metabolic Basis of Inherited Disease 1989 McGraw Hill New York, NY 915 931
163. Wanders RJA Duran M Ijlst L Sudden infant death and long-chain 3-hydroxyacyl-CoA dehydrogenase Lancet 2 1989 52 53
164. Hale DE Thorpe C Short-chain 3-OH acyl-CoA dehydrogenase deficiency Pediatr Res 25 1989 119A
165. Tein I De Vivo DC Bierman F Impaired skin fibroblast carnitine uptake in primary systemic carnitine deficiency manifested by childhood carnitine-responsive cardiomyopathy Pediatr Res 28 1990 247 255
166. Stanley CA Hale DE Coates PM Medium-chain acyl-CoA dehydrogenase deficiency Tanaka K Coates PM Fatty Acid Oxidation: Clinical, Biochemical and Molecular Aspects 1990 Liss New York, NY 291 302
167. Stanley CA New genetic defects in mitochondrial fatty acid oxidation and carnitine deficiency Adv Pediatr 34 1987 59 88
168. Cahill GF Jr Starvation in man N Engl J Med 282 1970 668 675
169. Hale DE Bennett MJ Fatty acid oxidation disorders: A new class of metabolic diseases J Pediatr 121 1992 1 11
170. Pildes RS Patel DA Nitzan M Glucose disappearance rate in symptomatic neonatal hypoglycemia Pediatrics 52 1973 75 82
171. Bier DM Leake RD Haymond MW Measurement of “true” glucose production rates in infancy and childhood with 6,6-dideuteroglucose Diabetes 26 1977 1016 1023
172. Aynsley-Green A Hypoglycemia in infants and children Clin Endocrinol Metab 11 1982 159 194
173. Pagliara AS Karl IE Haymond M Hypoglycemia in infancy and childhood, Part 1 J Pediatr 82 1973 365 379
174. Stremmel W Strohmeyer G Berk PD Hepatocellular uptake of oleate is energy dependent, sodium linked, and inhibited by an antibody to a hepatocyte plasma membrane fatty acid binding protein Proc Natl Acad Sci U S A 83 1986 3584 3588
175. Schulz H Oxidation of fatty acids Vance DE Vance JE Biochemistry of Lipids and Membranes 1985 Benjamin Cummings Publishing Company Menlo Park, CA 116 142
176. Murthy MSR Pande SV Malonyl-CoA binding site and the overt carnitine palmitoyltransferase activity reside on the opposite sides of the outer mitochondrial membrane Proc Natl Acad Sci U S A 84 1987 378 382
177. Pande SV A mitochondrial carnitine acylcarnitine translocase system Proc Natl Acad Sci U S A 72 1975 883 887
178. Ikeda Y Dabrowski C Tanaka K Separation and properties of five distinct acyl-CoA dehydrogenases from rat liver mitochondria. Identification of a new 2-methyl-branched-chain acyl-CoA dehydrogenase J Biol Chem 258 1983 1066 1076
179. Fong JC Schulz H Short-chain and long-chain enoyl-CoA hydratases from pig heart muscle Methods Enzymol 71 1981 390 398
180. El-Fakhri M Middleton B The existence of an inner-membrane-bound, long acyl-chain-specific 3-hydroxy-acyl-CoA dehydrogenase in mammalian mitochondria Biochem Biophys Acta 713 1982 270 279
181. Middleton B 3-Ketoacyl-CoA thiolases of mammalian tissues Lowenstein JM Methods Enzymol, Lipids, Part B vol 35 1975 Academic Press New York, NY 128 136
182. Kelley RI Beta-oxidation of long-chain fatty acids by human fibroblasts: evidence for a novel long-chain acyl-coenzyme A dehydrogenase Biochem Biophys Res Commun 182 1992 1002 1007
183. Izai K Uchida Y Orii T Novel fatty acid β-oxidation enzymes in rat liver mitochondria. I. Purification and properties of very long-chain acyl-coenzyme A dehydrogenase J Biol Chem 267 1992 1027 1033
184. New Developments in Fatty Acid Oxidation Hashimoto T Peroxisomal and mitochondrial enzymes Coates PM Tanaka K Progress in Clinical and Biological Research vol 375 1992 Wiley New York, NY 19 32
185. Carpenter K Pollitt RJ Middleton B Human liver long-chain 3-hydroxyacyl-coenzyme A dehydrogenase is a multifunctional membrane-bound beta-oxidation enzyme of mitochondria Biochem Biophys Res Commun 183 1992 443 448
186. Luo MJ He X-Y Sprecher H Purification and characterization of the trifunctional β-oxidation complex from pig heart mitochondria Arch Biochem Biophys 304 1993 266 271
187. Reed WD Lane MD Mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthetase from chicken liver Lowenstein JM Methods Enzymol, Lipids, Part B vol 35 1975 Academic Press New York, NY 155 177
188. Krahling JB Gee R Murphy PA Comparison of fatty acid oxidation in mitochondria and peroxisomes from rat liver Biochem Biophys Res Commun 82 1978 136 141
189. Kølvraa S Gregersen N Acyl-CoA: Glycine n-acyltransferase: Organelle localization and affinity toward straight- and branched-chained acyl-CoA esters in rat liver Biochem Med Metab Biol 36 1986 98 105
190. Roe CR Millington DS Maltby DA Diagnostic and therapeutic implications of medium-chain acylcarnitines in the medium-chain acyl-CoA dehydrogenase deficiency Pediatr Res 19 1985 459 466
191. Baretz BH Ramsdell HS Tanaka K Identification of n-hexanoylglycine in urines from two patients with Jamaican vomiting sickness Clin Chim Acta 73 1976 199 202
192. Millington DS New methods for the analysis of acylcarnitines and acyl-coenzyme A compounds Gaskell SJ Mass Spectrometry in Biomedical Research 1986 John Wiley New York, NY 97 114
193. Johnson RE Possmore R Sargent F Multiple factors in experimental human ketosis Arch Intern Med 107 1961 43 50
194. Bell AW Thompson GE Free fatty acid oxidation in bovine muscle in vivo: effects of cold exposure and feeding Am J Physiol 237 1979 E309 E315
195. Tonsgard JH Getz GS Effect of Reye's syndrome serum on isolated chinchilla liver mitochondria J Clin Invest 76 1985 816 825
196. Tonsgard JH Serum dicarboxylic acids in patients with Reye syndrome J Pediatr 109 1986 440 445
197. Corkey BE Hale DE Glennon MC Relationship between unusual hepatic acyl coenzyme A profiles and the pathogenesis of Reye syndrome J Clin Invest 82 1988 782 788
198. Mak IT Kramer JH Weglicki WB Potentiation of free radical-induced lipid peroxidative injury to sarcolemmal membranes by lipid amphiphiles J Biol Chem 26 1986 1153 1157
199. Inoue D Pappano AJ L-palmitoylcarnitine and calcium ions act similarly on excitatory ionic currents in avian ventricular muscle Circ Res 52 1983 625 634
200. Spedding M Activators and inactivators of Ca++ channels: New perspectives J Pharmacol (Paris) 16 1985 319 343
201. Spedding M Mir AK Direct activation of Ca++ channels by palmitoyl carnitine, a putative endogenous ligand Br J Pharmacol 92 1987 457 468
202. Lee HC Smith N Mohabir R Cytosolic calcium transients from the beating mammalian heart Proc Natl Acad Sci U S A 84 1987 7793 7797
203. Bremer J Carnitine-metabolism and functions Physiol Rev 63 1983 1420 1480
204. Stanley CA Deleeuw S Coates PM Chronic cardiomyopathy and weakness or acute coma in children with a defect in carnitine uptake Ann Neurol 30 1991 709 716
205. Knochel JP Renal injury in muscle disease Suki WN Eknoyan G The Kidney in Systemic Disease 1976 Wiley New York, NY 129 140
206. Tein I Fatty acid oxidation and associated defects Proceedings of the American Academy of Neurology Seattle, WA 1995 Omnipress Madison, WI 9 38
207. Elpeleg ON Joseph A Branski D Recurrent metabolic decompensation in profound carnitine palmitoyl-transferase II deficiency J Pediatr 122 1993 917 919
208. (abstr) Poll-The BT Duran M Mousson B Carnitine palmitoyl transferase I deficiency: Is there a diagnostic dicarboxylic aciduria? Proceedings of the 30th Annual Symposium of the Society for the Study of Inborn Errors of Metabolism Leuven, Scotland Sept. 8–11, 1992 128
209. Tripp ME Katcher ML Peters HA Systemic carnitine deficiency presenting as familial endocardial fibroelastosis. A treatable cardiomyopathy N Engl J Med 305 1981 385 390
210. Falik-Borenstein ZC Jordan SC Saudubray J-M Brief report: Renal tubular acidosis in carnitine palmitoyltransferase type 1 deficiency N Engl J Med 327 1992 24 27
211. DiMauro S Papadimitriou A Carnitine palmitoyl-transferase deficiency Engel AG Banker BQ Myology vol 2 1986 McGraw-Hill New York, NY 1697 1708
212. Demaugre F Bonnefont JP Colonna M Infantile form of carnitine palmitoyltransferase II deficiency with hepatomuscular symptoms and sudden death. Physiopathological approach to carnitine palmitoyltransferase II deficiencies J Clin Invest 87 1991 859 864
213. Hug G Bove KE Soukup S Lethal neonatal multiorgan deficiency of carnitine palmitoyltransferase II N Engl J Med 325 1991 1862 1864
214. Fatty Acid Oxidation: Clinical, Biochemical and Molecular Aspects Hale DE Stanley CA Coates PM The long-chain acyl-CoA dehydrogenase deficiency Tanaka K Coates Progress in Clinical and Biological Research vol 321 1990 Liss New York, NY 303 311
215. Glasgow AM Engel AG Bier DM Hypoglycemia, hepatic dysfunction, muscle weakness, cardiomyopathy, free carnitine deficiency and long-chain acylcarnitine excess responsive to medium-chain triglyceride diet Pediatr Res 17 1983 319 326
216. Tein I Donner EJ Hale DE Clinical and neurophysiologic response of myopathy and neuropathy in long-chain L-3-hydroxyacyl-CoA dehydrogenase deficiency to oral prednisone Pediatr Neurol 12 1995 68 76
217. Hagenfeldt L von Döbein U Holme E 3-Hydroxydicarboxylic aciduria—a fatty acid oxidation defect with severe prognosis J Pediatr 116 1990 387 392
218. Stanley CA Sunaryo F Hale DE Elevated plasma carnitine in the hepatic form of carnitine palmitoyltransferase-1 deficiency J Inherit Metab Dis 15 1992 785 789
219. New Developments in Fatty Acid Oxidation Millington DS Terada N Chace DH The role of tandem mass spectrometry in the diagnosis of fatty acid oxidation disorders Tanaka K Coates PM Progress in Clinical and Biological Research vol 375 1992 Wiley-Liss New York, NY 339 354
220. Kerner J Bieber LL A radioisotopic exchange method for quantitation of short-chain (acid soluble) acylcarnitines Anal Biochem 134 1983 459 466
221. 10-dicarboxylic aciduria: Biochemical considerations in relation to diagnosis of β-oxidation defects Scand J Clin Lab Invest 42 suppl 161 1982 15 27
222. Mortensen PB Gregersen N The biological origin of ketotic dicarboxylic aciduria. II. In vivo and in vitro investigations of the β-oxidation of C8-C16-dicarboxylic acids in unstarved, starved and diabetic rats Biochim Biophys Acta 710 1982 477 484
223. Mortensen PB Inhibition of fatty acid oxidation by valproate Lancet 2 1981 856 857
224. Fatty Acid Oxidation: Clinical, Biochemical and Molecular Aspects Hale DE Thorpe C Braat K The L-3-hydroxyacyl-CoA dehydrogenase deficiency Tanaka K Coates PM Progress in Clinical and Biological Research vol 321 1990 Liss New York, NY 503 510
225. Fatty Acid Oxidation: Clinical Biochemical, and Molecular Aspects Pollitt RJ Clinical and biochemical presentations in twenty cases of hydroxydicarboxylic aciduria Tanaka K Coates PM Progress in Clinical and Biological Research vol 321 1990 Liss New York, NY 495 502
226. Gregersen N Kølvraa S Mortensen PB Acyl-CoA: glycine N-acyltransferase: In vitro studies on the glycine conjugation of straight- and branched-chained acyl-CoA esters in human liver Biochem Med Metab Biol 35 1986 210 218
227. Fatty Acid Oxidation: Clinical, Biochemical and Molecular Aspects Rhead WJ Screening for inborn errors of fatty acid oxidation in cultured fibroblasts: an overview Tanaka K Coates PM Progress in Clinical and Biological Research vol 321 1990 Liss New York, NY 365 382
228. Esser V Britton CH Weis BC Cloning, sequencing, and expression of a cDNA encoding rat liver carnitine palmitoyltransferase I J Biol Chem 268 1993 5817 5822
229. Indiveri C Tonazzi A Palmieri F Identification and purification of the carnitine carrier from rat liver mitochondria Biochim Biophys Acta 1020 1990 81 86
230. Indiveri C Tonazzi A Prezioso G Kinetic characterization of the reconstituted carnitine carrier from rat liver mitochondria Biochim Biophys Acta 1065 1991 231 238
231. Woeltje KF Esser V Weist BC Cloning, sequencing, and expression of a cDNA encoding rat liver mitochondrial carnitine palmitoyltransferase II J Biol Chem 265 1990 10720 10725
232. Finocchiaro G Taroni F Rocchi M cDNA cloning, sequence analysis, and chromosomal localization of the gene for human carnitine palmitoyltransferase Proc Natl Acad Sci U S A 88 1991 661 665
233. Taroni F Verderio E Dworzak F Identification of a common mutation in the carnitine palmitoyltransferase II gene in familial recurrent myoglobinuria patients Nature Genet 4 1993 314 320
234. Matsubara Y Indo Y Naito E Molecular cloning and nucleotide sequence of cDNAs encoding the precursors of rat long chain acyl coenzyme A, short chain acyl coenzyme A and isovaleryl-coenzyme A dehydrogenases: Sequence homology of four enzymes of the Acyl-CoA Dehydrogenase Family J Biol Chem 264 1989 16321 16331
235. Indo Y Tang-Feng T Glassberg R Molecular cloning and nucleotide sequence of cDNAs encoding human long chain acyl-CoA dehydrogenase and assignment of the location of its gene (ACADL) to chromosome 2 Genomics 11 1991 609 620
236. Kelly DP Kim JJ Billadello JJ Nucleotide sequence of MCAD mRNA Proc Natl Acad Sci U S A 84 1987 4068 4072
237. Fatty Acid Oxidation: Clinical, Biochemical and Molecular Aspects Strauss AW Duran M Zhang Z Molecular analysis of medium chain acyl-CoA dehydrogenase deficiency Tanaka K Coates PM Progress in Clinical and Biological Research vol 321 1990 Liss New York, NY 609 623
238. Gregersen N Andrese BS Bross P Characterization of a disease-causing Lys329 to Glu mutation in 16 patients with medium-chain acyl-CoA dehydrogenase deficiency J Inherit Metab Dis 14 1991 314 316
239. Finocchiaro G Ito M Tanaka K Purification and properties of short chain acyl-CoA, medium chain acyl-CoA, and isovaleryl-CoA dehydrogenases from human liver J Biol Chem 262 1987 7982 7989
240. Naito E Ozasa H Ikeda Y Molecular cloning and nucleotide sequence of complementary DNAs encoding human short chain acyl-coenzyme A dehydrogenase and the study of the molecular basis of human short chain acyl-coenzyme A dehydrogenase deficiency J Clin Invest 83 1989 1605 1613
241. Finochiaro G Ito M Ikeda Y Molecular cloning and nucleotide sequence of cDNAs encoding the α-subunit of human electron transfer flavoprotein J Biol Chem 265 1988 15773 15780
242. Indo Y Glassberg R Yokota I Molecular characterization of variant α-subunit of electron transfer flavoprotein in three patients with glutaric acidemia type II—and identification of glycine substitution for valine-157 in the sequence of the precursor, producing an unstable mature protein in a patient Am J Hum Genet 49 1991 575 580
243. Finocchiaro G Colombo I Garavaglia B cDNA cloning and mitochondrial import of the beta subunit of the human electron-transfer flavoprotein Eur J Biochem 213 1993 1003 1008
244. New Developments in Fatty Acid Oxidation Goodman SI Bemelen KF Frerman FE Human cDNA encoding ETF dehydrogenase (ETF;ubiquinone oxidoreductase), and mutations in glutaric acidemia type II Coates PM Tanaka K Progress in Clinical and Biological Research vol 375 1992 Wiley-Liss Inc New York, NY 567 572
245. Mitchell GA Robert M-F Hruz PW 3-Hydroxy-3-methylglutaryl coenzyme A lyase (HL). Cloning of human and chicken liver HLcDNAs and characterization of a mutation causing human HL deficiency J Biol Chem 25 1993 4376 4381
246. Roberts JR Narasimhan C Hruz PW 3-Hydroxy-3-methylglutaryl-CoA lyase: Expression and isolation of the recombinant human enzyme and investigation of a mechanism for regulation of enzyme activity J Biol Chem 269 1994 17841 17846
247. Pande SV Brivet M Slama A Carnitine-acylcarnitine translocase deficiency with severe hypoglycemia and auriculoventricular block J Clin Invest 91 1993 1247 1252
248. Treem WR Stanley CA Finegold DN Primary carnitine deficiency due to a failure of carnitine transport in kidney, muscle and fibroblasts N Engl J Med 319 1988 1331 1336
249. Fatty Acid Oxidation: Clinical, Biochemical and Molecular Aspects Finocchiaro G Ikeda Y Ito M Biosynthesis, molecular cloning and sequencing of electron transfer flavoprotein Tanaka K Coates PM Progress in Clinical and Biological Research vol 321 1990 Liss New York, NY 637 652
250. 10-dicarboxylic aciduria: Investigations of a patient with riboflavin responsive multiple acyl-CoA dehydrogenation defects Pediatr Res 16 1982 861 868
251. Fatty Acid Oxidation, Clinical, Biochemical, and Molecular Aspects Stanley CA Hale DE Coates PM Medium-chain acyl-CoA dehydrogenase deficiency Tanaka K Coates PM Progress in Clinical and Biological Research vol 321 1990 Liss New York, NY 291 302
252. Bennett MJ Worthy E Pollitt RJ The incidence and presentation of dicarboxylic aciduria J Inherit Metab Dis 10 1987 241 242
253. Blakemore AIF Singleton H Pollitt RJ Frequency of the G985 MCAD mutation in the general population Lancet 337 1991 298 299
254. Luft R Ikkos D Palmieri G A case of severe hypermetabolism of nonthyroid origin with a defect in the maintenance of mitochondrial respiratory control: A correlated clinical, biochemical, and morphological study J Clin Invest 41 1962 1176 1804
255. Shy GM Gonatas NK Human myopathy with giant abnormal mitochondria Science 145 1964 493 496
256. Shy GM Gonatas NK Perez M Two childhood myopathies with abnormal mitochondria. I. Megaconial myopathy. II. Pleoconial myopathy Brain 89 1966 133 158
257. DiMauro S Mitochondrial Encephalomyopathies Rosenberg RN Prusiner SB DiMauro S The Molecular and Genetic Basis of Neurological Disease 1993 Butterworth-Heinemann Boston, MA 665 694
258. Uemura A Osame M Nakagawa M Leber's hereditary optic neuropathy: Mitochondrial and biochemical studies on muscle biopsies Br J Ophthalmol 71 1987 531 536
259. (suppl) Stadhouders A Jap P Walliman TH Biochemical nature of mitochondrial crystals J Neurol Sci 98 1990 304 305
260. Jerusalem F Angelini C Engel AG Mitochondria-lipid-glycogen (MLG) disease of muscle Arch Neurol 29 1973 162 169
261. Molecular, Cellular, and Medical Aspects DiMauro S De Vivo DC Diseases of carbohydrate, fatty acid, and mitochondrial metabolism Siegel GJ Basic Neurochemistry 4th ed 1989 Raven New York, NY 647 670
262. Nass S Nass MMK Intramitochondrial fibers with DNA characteristics J Cell Biol 19 1963 593 629
263. Anderson S Bankier AT Barrell BG Sequence and organization of the human mitochondrial genome Nature 290 1981 457 465
264. Giles RE Blanc H Cann RM Maternal inheritance of human mitochondrial DNA Proc Natl Acad Sci U S A 83 1980 9611 9615
265. Moraes CT Shanske S Tritschler HJ MtDNA depletion with variable tissue expression: A novel genetic abnormality in mitochondrial diseases Am J Hum Genet 48 1991 492 501
266. Wallace DC Zheng X Lott MT Familial mitochondrial encephalomyopathy (MERRF): Genetic, pathophysiological and biochemical characterization of a mitochondrial DNA disease Cell 55 1988 601 610
267. Schatz G The mitochondrial protein import machinery Sato T DiMauro S Mitochondrial encephalomyopathies 1991 Raven Press New York, NY 57 74
268. Haller RG Lewis SF Eastabrook RW Exercise intolerance, lactic acidosis, and abnormal cardiopulmonary regulation in exercise associated with adult skeletal muscle cytochrome c oxidase deficiency J Clin Invest 84 1989 155 161
269. (suppl 1) Lewis SF Haller RG Physiologic measurement of exercise and fatigue with special reference to chronic fatigue syndrome Rev Infect Dis 13 1991 S98 S108
270. 1 subunit of the human pyruvate dehydrogenase complex Genomics 4 1989 174 181
271. Ho L Javed AA Pepin RA Identification of a cDNA clone for the beta-subunit of the pyruvate dehydroge Biochem Biophys Res Commun 150 1988 904 908
272. Robinson BH Lactic acidemia Scriver CR Beaudet AL Sly WS The Metabolic Basis of Inherited Disease 6th ed. 1989 McGraw-Hill New York, NY 869 888
273. Hatefi Y The mitochondrial electron transport and oxidative phosphorylation system Annu Rev Biochem 54 1985 1015 1069
274. Moreadith RW Batshaw ML Ohnishi T Deficiency of the iron-sulfur clusters of mitochondrial reduced nicotinamide-adenine dinucleotide-ubiquinone oxidoreductase (complex I) in an infant with congenital lactic acidosis J Clin Invest 74 1984 685 697
275. Robinson BH Ward J Goodyer P Respiratory chain defects in the mitochondria of cultured skin fibroblasts from three patients with lactic acidemia J Clin Invest 77 1986 1422 1427
276. Day CE Scheffler IE Mapping of the genes of some components of the electron transport chain (complex I) on the X chromosome of mammals Somat Cell Genet 8 1982 691 707
277. Morgan-Hughes JA Schapira AHV Cooper JM Molecular defects of NADH-ubiquinone oxidoreductase (complex I) in mitochondrial diseases J Bioenerg Biomembr 20 1988 365 382
278. Arts WFM Scholte HR Bogaard JM NADH-CoQ reductase deficiency myopathy: Successful treatment with riboflavin Lancet 2 1983 581 582
279. abstr Garavaglia B Antozzi C Girotti F A mitochondrial myopathy with complex II deficiency Neurology 40 suppl 1 1990 294
280. Birch-Machin MA Shepherd IM Watmaugh NJ Fatal lactic acidosis in infancy with a defect of complex III of the respiratory chain Pediatr Res 25 1989 553 559
281. Morgan-Hughes JA Hayes DJ Cooper M Mitochondrial myopathies: Deficiencies localized to complex I and complex III of the mitochondrial respiratory chain Biochem Soc Trans 13 1985 648 650
282. 1 complex in mitochondrial diseases J Bioenerg Biomembr 20 1988 325 352
283. Darley-Usmar VM Watanabe M Uchiyama Y Mitochondrial myopathy: Tissue-specific expression of a defect in ubiquinol-cytochrome c reductase Clin Chim Acta 158 1986 253 261
284. 3 and C in a patient with a defect in electron transport at complex III in skeletal muscle Proc Natl Acad Sci U S A 81 1984 3529 3533
285. Darley-Usmar VM Kennaway NG Buist NR Deficiency in ubiquinone cytochrome c reductase in a patient with mitochondrial myopathy and lactic acidosis Proc Natl Acad Sci U S A 80 1983 5103 5106
286. 31P-NMR follow-up study Ann Neurol 19 1986 598 602
287. Przyrembel H Therapy of mitochondrial disorders J Inherit Metab Dis 10 suppl 2 1987 129 146
288. Reichmann H Rohkamm R Zeviani M Mitochondrial myopathy due to Complex III deficiency with normal reducible cytochrome b concentration Arch neurol 43 1986 957 961
289. Slipetz DM Aprille JR Goodyer PR Deficiency of complex III of the mitochondrial respiratory chain in a patient with facioscapulohumeral disease Am J Hum Genet 48 1991 502 510
290. Papadimitriou A Neustein HB DiMauro S Histiocytoid cardiomyopathy of infancy: Deficiency of reducible cytochrome b in heart mitochondria Pediatr Res 18 1984 1023 1028
291. Kadenbach B Ungibauer BM Jarausch J The complexity of respiratory complexes Trends Biochem Sci 8 1983 398 400
292. DiMauro S Lombes A Nakase H Cytochrome c oxidase deficiency Pediatr Res 28 1990 536 541
293. (abstr) Koga Y Fabrizi GM Mita S Sequence of a cDNA specifying subunit VIIc of human cytochrome c oxidase Nucleic Acids Res 18 1990 684
294. Tritschler H-J Bonilla E Lombes A Differential diagnosis of fatal and benign cytochrome c oxidase-deficient myopathies of infancy: An immunohistochemical approach Neurology 41 1991 300 305
295. Zeviani M Van Dyke DH Servidei S Myopathy and fatal cardiopathy due to cytochrome c oxidase deficiency Arch Neurol 43 1986 1198 1202
296. Hart Z Chang CH A newborn infant with respiratory distress and stridulous breathing J Pediatr 113 1988 150 155
297. DiMauro S Nicholson JF Hays AP Benign infantile mitochondrial myopathy due to reversible cytochrome c oxidase deficiency Ann Neurol 14 1983 226 234
298. Van Coster R Lombes A DeVivo DC Cytochrome c oxidase-associated Leigh syndrome: Phenotypic features and pathogenetic speculations J Neurol Sci 104 1991 97 111
299. Miranda AF Ishii S DiMauro S Cytochrome c oxidase deficiency in Leigh's deficiency: Genetic evidence for a nuclear DNA-encoded mutation Neurology 39 1989 697 702
300. (letter) Ruitenbeek W Sengers R Albani M Prenatal diagnosis of cytochrome c oxidase deficiency by biopsy of chorionic villi N Engl J Med 319 1988 1095
301. 3 in muscle: A report of two unrelated patients Clin Neurol Neurosurg 85 1983 57 70
302. Bardosi A Creutzfeldt W DiMauro S Myoneuro-, gastrointestinal eneephalopathy (MNGIE syndrome) due to partial deficiency of cytochrome c oxidase Acta Neuropathol 74 1987 248 258
303. Schotland DL DiMauro S Bonilla E Neuromuscular disorder associated with a defect in mitochondrial energy supply Arch Neurol 33 1976 475 479
304. Clark JB Hayes DJ Byrne E Mitochondrial myopathies: Defects in mitochondrial metabolism in human skeletal muscle Biochem Soc Trans 11 1983 626 627
305. Haydar NA Conn HL Afifi A Severe hypermetabolism with primary abnormality of skeletal muscle mitochondria Ann Intern Med 74 1971 548 558
306. DiMauro S Bonilla E Lee CP Luft's disease. Further biochemical and ultrastructural studies of skeletal muscle in the second case J Neurol Sci 27 1976 217 232
307. Moraes CT DiMauro S Zeviani M Mitochondrial DNA deletions in progressive external ophthalmoplegia and Kearns-Sayre syndrome N Engl J Med 320 1989 1293 1299
308. Schapira AHV Cooper JM Morgan-Hughes JA Mitochondrial myopathy with a defect of mitochondrial protein transport N Engl J Med 323 1990 37 42
309. Holt IJ Harding AE Cooper JM Mitochondrial myopathies: Clinical and biochemical features of 30 patients with major deletions of muscle mitochondrial DNA Ann Neurol 26 1989 699 708
310. Goto Y Itami N Kajii N Renal tubular involvement mimicking Bartter syndrome in a patient with Kearns-Sayre syndrome J Pediatr 116 1990 904 910
311. Eviatar L Shanske S Gauthier B Kearns-Sayre syndrome presenting as renal tubular acidosis Neurology 40 1990 1761 1763
312. Moraes CT Zeviani M Schon EA Mitochondrial DNA deletion in a girl with manifestations of Kearns-Sayre and Lowe syndromes: An example of phenotypic mimicry? Am J Med Genet 41 1991 301 305
313. Zupanc ML Moraes CT Shanske S Deletion of mitochondrial DNA in patients with combined features of Kearns-Sayre and MELAS syndromes Ann Neurol 29 1991 680 683
314. Shoffner JM Lott MT Voljavec AS Spontaneous Kearns-Sayre/chronic external ophthalmoplegia plus syndrome associated with mitochondrial DNA deletion: A slip-replication model and metabolic therapy Proc Natl Acad Sci U S A 86 1989 7952 7956
315. Tanaka M Sato W Ohno K Direct sequencing of deleted mitochondrial DNA in myopathic patients Biochem Biophys Res Commun 164 1989 156 163
316. Mita S Rizzuto R Moraes CT Recombination via flanking direct repeats is a major cause of largescale deletions of human mitochondrial DNA Nucleic Acid Res 18 1990 561 567
317. Newman NJ Wallace DC Mitochondria and Leber's hereditary optic neuropathy Am J Ophthalmol 109 1990 726 730
318. Wallace DC Singh G Lott MT Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy Science 242 1988 1427 1430
319. Huoponen K Vilkki J Aula P A new mtDNA mutation associated with Leber hereditary optic neuroretinopathy Am J Hum Genet 48 1991 1147 1153
320. Parker WD Oley CA Parks JK A defect in mitochondrial electron-transport activity (NADH-Coenzyme Q oxidoreductase) in Leber's hereditary optic neuropathy N Engl J Med 320 1989 1331 1333
321. Lys mutation Cell 61 1990 931 937
322. (8344) mutation of mtDNA in Italian families with myoclonus epilepsy and ragged-red fibers (MERRF) Am J Hum Genet 48 1991 203 211
323. Hammans SR Sweeney MG Brockington M Mitochondrial encephalomyopathies: Molecular genetic diagnosis from blood samples Lancet 337 1991 1311 1313
324. (abstr) Tsairis P Engel WK Kark P Familial myoclonic epilepsy syndrome associated with skeletal muscle mitochondrial abnormalities Neurology 23 1973 408
325. Lombes A Mendell JR Nakase H Myoclonic epilepsy and ragged-red fibers with cytochrome c oxidase deficiency: Neuropathology, biochemistry, and molecular genetics Ann Neurol 26 1989 20 33
326. Berkovic SF Carpenter S Evans A Myoclonus epilepsy and ragged-red fibers (MERRF). 1. A clinical, pathological, biochemical, magnetic resonance spectrographic and positron emission tomographic study Brain 112 1989 1231 1260
327. Morgan-Hughes JA Hayes D Clark J Mitochondrial encephalomyopathies. Biochemical studies in two cases revealing defects in the respiratory chain Brain 105 1982 553 582
328. Chomyn A Meola G Bresolin N In vitro genetic transfer of protein synthesis and respiration defects to mitochondrial DNA-less cells with myopathy-patient mitochondria Moll Cell Biol 11 1991 2236 2244
329. King MP Attardi G Human cells lacking mtDNA: Repopulation with exogenous mitochondria by complementation Science 246 1989 500 503
330. 10 (CoQ) therapy Neurology 41 suppl 1 1991 280
331. Ciafaloni E Ricci E Shanske S MELAS: Clinical features, biochemistry, and molecular genetics Ann Neurol 31 1992 391 398
332. Pavlakis SG Phillips PC DiMauro S Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes: A distinctive clinical syndrome Ann Neurol 16 1984 481 488
333. Leu(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies Nature 348 1990 651 653
334. Leu(UUR) gene in MELAS Biochem Biophys Res Commun 173 1990 816 822
335. Sakuta R Nonaka I Vaseular involvement in mitochondrial myopathy Ann Neurol 25 1989 594 601
336. Ohama E Ohara S Ikuta F Mitochondrial angiopathy in cerebral blood vessels of mitochondrial encephalomyopathy Acta Neuropathol 74 1987 226 233
337. Ohama E Ikuta F Involvement of choroid plexus in mitochondrial encephalomyopathy (MELAS) Acta Neuropathol 76 1987 1 7
338. Kobayashi M Morishita H Sugiyama N Two cases of NADH-coenzyme Q reductase deficiency: Relationship to MELAS syndrome J Pediatr 110 1987 223 227
339. Koga Y Nonaka I Kobayashi M Findings in muscle in complex I (NADH Coenzyme Q reductase) deficiency Ann Neurol 24 1988 749 756
340. Shapira Y Cederbaum SD Cancilla PA Familial poliodystrophy, mitochondrial myopathy, and lactate acidemia Neurology 25 1975 614 621
341. Yamamoto M Sato T Anno M Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes with recurrent abdominal symptoms and coenzyme Q10 administration J Neurol Neurosurg Psychiatry 50 1987 1475 1481
342. De Vivo DC, Personal communication, May 1992
343. Holt IJ Harding AE Petty RKH A new mitochondrial disease associated with mitochondrial DNA heteroplasmy Am J Hum Genet 46 1990 428 433
344. Zeviani M Servidei S Gellera C An autosomal dominant disorder with multiple deletions of mitochondrial DNA starting at the D-loop region Nature 339 1989 309 311
345. Servidei S Zeviani M Manfredi G Dominantly inherited mitochondrial myopathy with multiple deletions of mitochondrial DNA: Clinical, morphologic, and biochemical studies Neurology 41 1991 1053 1059
346. Zeviani M Bresolin N Gellera C Nucleusdriven multiple large-scale deletions of the human mitochondrial genome: A new autosomal dominant disease Am J Hum Genet 47 1990 904 914
347. Cormier V Rotig A Tardieu M Autosomal dominant deletions of the mitochondrial genome in a case of progressive encephalomyopathy Am J Hum Genet 48 1991 643 648
348. Iannaccone ST Griggs RC Markesbery WR Familial progressive external ophthalmoplegia and raggedred fibers Neurology 24 1974 1033 1038
349. Yuzaki M Ohkoshi N Kanazawa I Multiple deletions in mitochondrial DNA at direct repeats of non-D-loop regions in cases of familial mitochondrial myopathy Biochem Biophys Res Commun 164 1989 1352 1357
350. Tritschler H-J Andreetta F Morares CT Mitochondrial myopathy of childhood associated with depletion of mitochondrial DNA Neurology 42 1992 209 217
351. Boustany RN Aprille JR Halperin J Mitochondrial cytochrome deficiency presenting as a myopathy with hypotonia, external ophthalmoplegia, and lactic acidosis in an infant and as fatal hepatopathy in a second cousin Ann Neurol 14 1983 462 470
352. Andreeta F Tritschler HJ Schon EA Localization of mitochondrial DNA in normal and pathological muscle using immunological probes: A new approach to the study of mitochondrial myopathies J Neurol Sci 105 1991 88 92
353. Robinson BH DeMeirleir LJ Glerum M Sherwood WG Becker L Clinical presentation of patients with mitochondrial respiratory chain defects in NADH-coenzyme Q reductase and cytochrome oxidase: Clues to the pathogenesis of Leigh disease J Pediatr 110 1987 216 222
354. Sabina RL Myoadenylate deaminase deficiency Rosenberg RN Prusiner SB DiMauro S The Molecular and Genetic Basis of Neurological Disease 1993 Butterworth-Heinemann Boston, MA 261 275
355. Fishbein WN Myoadenylate deaminase deficiency: Inherited and acquired forms Biochem Med 33 1985 158 169
356. Fishbein WN Griffin JL Armbrustmacher VW Stain for skeletal muscle adenylate deaminase: An effective tetrazolium stain for frozen biopsy specimens Arch Pathol Lab Med 104 1980 462 466
357. Sabina RL Morisaki T Clarke P Characterization of the human and rat myoadenylate deaminase genes J Biol Chem 265 1990 9423 9433